Tuesday, September 05, 2017 10:15 PM ET
Insiders at Glaukos (GKOS) Make Significant Stock Sales Extends the Trend of Last Quarter
Two insiders — OrbiMed Advisors Llc, Director, and Jonathan Silverstein, Director — today, disposed of 1,160,400 shares of Glaukos having a market value of approximately $44,945,644, as disclosed in form 4 documents filed with the SEC. There have been 2 insiders with buy/sell transactions in the past 90 days prior to these filings. All of these trades have been sales resulting in the disposition of 650,000 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 1,810,400 shares and have averaged 452,600 shares per transaction over this time period.
Glaukos insider trading represents a higher number of buy/sell trades than for the 15 peer company average over the last 90-day period. The Medical Devices & Implants peer group saw 11 buy/sell trades during this period for an average of 0.7 transactions per company. The number of shares per buy/sell trade for Glaukos insiders was also higher. Within the peer group there were 110,339 shares purchased and 711,027 shares sold with company insiders having sold 54,608 shares on average.
The data obtained in composing and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Today’s Insider Activity
* OrbiMed Advisors Llc, Director, sold 580,200 shares
* Jonathan Silverstein, Director, sold 580,200 shares
Using proprietary artificial intelligence methods, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at firstname.lastname@example.org. Copyright 2017 UpTick Data Technologies. All rights reserved.